Physical distancing, masks reduce spread of COVID-19 | Parents wrong about time children are on mobile devices | Diet/exercise intervention may help reduce pediatric LDL
June 2, 2020
CONNECT WITH SMARTBRIEF LinkedInFacebookTwitter
Pediatrics Today SmartBrief
SIGN UP ⋅   SHARE
 
Top Stories
Physical distancing, masks reduce spread of COVID-19
(Justin Heiman/Getty Images)
A systematic review of 172 studies on coronavirus transmission found that physical distancing and use of face masks and eye protection are the best ways to reduce the risk of COVID-19. The findings, published in The Lancet, showed good hygiene and regular hand-washing are also critical in preventing SARS, MERS and COVID-19.
Full Story: Reuters (6/2),  CNN (6/1) 
LinkedIn Twitter Facebook Email
A study in Pediatrics found that 34.8% of parents overestimated their child's mobile device usage duration, while 35.7% underestimated it. The findings, based on data involving 350 children ages 3 to 5, also showed that 35% of children had their own mobile devices and had an average daily usage of 115.3 minutes.
Full Story: HealthDay News (6/1),  2 Minute Medicine (6/1) 
LinkedIn Twitter Facebook Email
Pediatric Health Care
An individualized diet and physical activity counseling intervention was associated with reduced low-density lipoprotein cholesterol in primary school children, when compared with a control group, researchers reported in the European Journal of Nutrition. The study found consuming more high-fat vegetable oil-based spreads and less butter-based spreads was the biggest factor in decreasing LDL cholesterol concentrations, but drinking low-fat milk instead of high-fat milk also helped.
Full Story: NewKerala (India)/Indo-Asian News Service (5/31) 
LinkedIn Twitter Facebook Email
A study in Cancer Medicine found that patients with Hodgkin lymphoma treated at pediatric centers had higher rates of radiation therapy but had less cumulative doses of bleomycin and doxorubicin, compared with those treated in adult centers. The study, based on data involving 954 adolescents and young adults diagnosed with Hodgkin lymphoma, also found no difference in 10-year event-free survival between those treated at community cancer, pediatric cancer and adult cancer centers.
Full Story: Physician's Briefing/HealthDay News (5/29) 
LinkedIn Twitter Facebook Email
Across four trials, mucositis, infections, hyperglycemia and other grade 3 or higher adverse events occurred at significantly higher rates in children with acute lymphoblastic leukemia and Down syndrome, compared with ALL patients without Down syndrome, according to a study presented at the American Society of Clinical Oncology Virtual Scientific Program. The findings, based on data involving 22,446 individuals with newly diagnosed ALL, also showed that children with Down syndrome had lower rates of event-free survival and overall survival than those without Down syndrome.
Full Story: Healio (free registration)/HemOnc Today (5/31) 
LinkedIn Twitter Facebook Email
Researchers studied 40 youths with Crohn's disease and found that those who underwent hypnosis intervention had significant improvements in reported quality of life, maximum abdominal pain intensity, school absences and in Pain Beliefs Questionnaire short form, compared with controls. The findings, presented at the Digestive Disease Week, also showed that patients who employed self-hypnosis three to four times a week had greater quality of life improvement compared with those who did it less often.
Full Story: Healio (free registration) (6/1) 
LinkedIn Twitter Facebook Email
Trends & Technology
A study published in JAMA Network Open showed EHRs consistently fail to detect up to one-third of dangerous drug interactions and medication administration errors in hospitalized patients. Researchers used an EHR safety evaluation tool to feed simulated medical records into EHRs at 2,314 US hospitals, and the EHRs correctly flagged potential drug problems only 66% of the time in 2018, up from 54% in 2009.
Full Story: United Press International (5/29) 
LinkedIn Twitter Facebook Email
Sutter Health's investment in home-based reading diagnostic workstations helped reduce median STAT exam turnaround times by 50% and improved overall median STAT turnaround across the organization despite the surge in patients undergoing imaging exams amid the COVID-19 pandemic, and the health system has also used flexible scheduling of shifts to address the influx of cases, writes Dr. Jason Wiesner, medical director of Sutter Health's diagnostic imaging service line and executive director of imaging informatics. "As we prepare for additional surges in the coming weeks and months, we are fully engaged in business-continuity planning to ensure that our radiologists have the tools to provide our patients with access to the best possible care," Wiesner writes.
Full Story: AuntMinnie (free registration) (6/1) 
LinkedIn Twitter Facebook Email
SmartBrief Originals
Sponsored content brought to you by SmartBrief
Health Policy & Regulations
Emergent BioSolutions was awarded a $628 million contract with the US government through the Biomedical Advanced Research and Development Authority to build COVID-19 vaccine manufacturing capacity. The task order requires Emergent to use its Baltimore Bayview facility, designed for rapid production of large quantities of treatments and vaccines during emergencies, for the production of COVID-19 vaccine candidates through 2021.
Full Story: Reuters (6/1) 
LinkedIn Twitter Facebook Email
Sharing Pediatrics Today SmartBrief with your network keeps the quality of content high and these newsletters free.
Help Spread the Word
SHARE
Or copy & share your personalized link:
smartbrief.com/pediatrics/?referrerId=eSriBJbAIQ
The easier it is to do something, the harder it is to change the way you do it.
Steve Wozniak,
co-founder of Apple, electronics engineer, programmer, philanthropist, entrepreneur
LinkedIn Twitter Facebook Email
 
SmartBrief publishes more than 200 free industry newsletters - Browse our portfolio
Sign Up  |    Update Profile  |    Advertise with SmartBrief
Unsubscribe  |    Privacy policy
CONTACT US: FEEDBACK  |    ADVERTISE
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004